Liquidia Technologies Inc (LQDA) Peer Comparison

$45.54

$-1.85 (-3.89%)

As on 05-Nov-2026 12:36EST

Market cap

$4,033 Mln

Revenue (TTM)

$451 Mln

P/E Ratio

32.4

P/B Ratio

20.7

Div. Yield

0 %

Edit

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Market cap ($ Mln)	4,033	14,600	11,611	11,755	8,769
Revenue ($ Mln)	451	946	5,020	331,377	831
Net Profit ($ Mln)	138.61	-570.21	-199.00	28,032.40	54.90
Net Margin (%)	30.74	-60.30	-3.96	8.46	6.61
RoE (%)	115.57	--	-3.03	7.51	8.11
Price to Earnings	32.42	--	--	39.19	180.27
Price-To-Book	20.66	123.68	1.72	2.91	12.42

Income Statement ($ Mln)

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Operating Revenue	450.91	945.54	5,020.00	331,377.21	830.81
Cost of Revenue	33.93	61.34	2,380.00	167,448.74	14.09
Gross Profit	145.08	473.81	2,050.00	190,428.00	748.43
Operating Expenses	248.41	1,294.12	2,178.00	134,367.32	810.32
Operating Profit (EBIT)	168.58	-409.91	462.00	29,561.14	6.41
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	149.50	-578.95	-166.00	35,270.62	26.37
Provision for Tax	10.90	-4.96	33.00	7,639.53	-35.26
Profit after Tax (Net Income)	138.61	-570.21	-199.00	28,032.40	54.90
Minority Interest	0.00	11.75	0.00	401.00	0.00
Consolidated Profit	0.00	0.00	0.00	12,099.00	0.00

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Shareholder's Funds	195.11	-1,662.34	6,588.00	387,871.57	705.78
Minority Interest	0.00	11.75	0.00	401.00	0.00
Non-Current Liabilities	137.51	2,838.05	5,121.00	30,754.20	29.12
Current Liabilities	189.30	977.24	1,852.00	155,168.12	153.80
Total Liabilities	327.93	936.03	13,358.00	492,989.00	836.65

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Non-Current Assets	84.21	117.18	9,764.00	278,119.64	449.03
Current Assets	437.71	2,044.61	3,797.00	298,879.23	439.68
Total Assets	327.93	936.03	13,358.00	492,989.00	836.65
Total Debt*	128.94	2,494.05	3,918.00	72,603.83	9.42
Net Current Assets	248.41	1,067.37	1,945.00	143,084.00	285.87

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Cash From Operating Activities	-35.69	-445.91	560.00	46,428.00	142.00
Cash Flow from Investing Activities	-6.34	-24.49	-279.00	-58,077.00	69.76
Cash from Financing Activities	59.73	359.29	-275.00	18,911.00	-220.37
Net Cash Inflow / Outflow	--	--	--	--	--

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
ROCE (%)	-31.16	-159.44	-2.21	16.61	14.87
ROE (%)	115.57	41.15	-3.03	7.51	8.11
ROA (%)	26.48	-26.19	-1.30	3.93	5.52
EBIT Margin (%)	39.06	-47.10	1.61	9.79	3.17
Net Margin (%)	30.74	-60.30	-3.96	8.46	6.61
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Revenue Growth (%)	2,233.65	167.27	11.95	-3.15	16.02
EBIT Growth (%)	242.30	34.77	-90.61	-59.13	-79.11
Net Profit Growth (%)	197.98	28.47	-145.85	-52.18	-58.66
EPS Growth (%)	180.97	30.63	-146.42	-52.16	-62.44
Book Value Growth (%)	984.36	16.42	-3.87	8.16	12.98

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Price / Earnings	-50.07	-20.69	-48.47	0.19	41.86
Price / Book Value	77.12	-7.27	1.72	0.03	6.44
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-80.00	-25.47	21.77	0.00	55.67
Market Cap ($ Cr)	--	--	--	--	--

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Debt to Equity	0.63	-1.16	0.58	0.03	0.00
Short term debt to equity ratio	0.00	-0.33	0.01	0.16	0.00
Current Ratio	2.31	2.09	2.05	1.93	2.86
Quick Ratio	2.12	2.03	1.10	1.40	2.77
Interest Coverage	6.61	-3.33	0.36	8.78	--

	Liquidia Technologies Inc (LQDA)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Dr. Reddy's Laboratories - ADR	Corcept Therapeutics (CORT)
Debtors to sales (%)	24.08	39.67	22.95	30.73	9.26
Asset Turnover	0.86	0.43	0.33	0.46	0.84
Receivable days	65.53	52.44	70.73	115.08	28.27
Inventory Days	331.59	172.81	226.89	181.99	355.76
Payable days	115.39	296.14	45.50	56.23	785.55
Cash Conversion Cycle	281.73	-70.89	252.12	240.84	-401.52

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.